Are beta‑blockers indicated for an acute coronary syndrome ST‑segment elevation myocardial infarction caused by coronary vasospasm?

Beta-Blockers Are Generally CONTRAINDICATED in STEMI Due to Coronary Vasospasm

Beta-blockers should be avoided in acute coronary syndrome caused by coronary vasospasm, as they can worsen vasospasm through unopposed alpha-adrenergic stimulation and are potentially harmful in this specific etiology.

Why Beta-Blockers Are Problematic in Vasospastic ACS

While the 2025 ACC/AHA/ACEP/NAEMSP/SCAI guidelines strongly recommend early beta-blocker therapy (within 24 hours) for most ACS patients to reduce reinfarction and ventricular arrhythmias 1, this recommendation does not apply to vasospasm-mediated STEMI. Here's the critical distinction:

Mechanism of Harm

• Beta-blockers work by reducing myocardial oxygen demand through decreased heart rate, blood pressure, and contractility 1
• In vasospastic angina, the problem is supply-side (coronary artery constriction), not demand-side
• Non-selective beta-blockers can worsen coronary vasospasm by allowing unopposed alpha-adrenergic vasoconstriction 2
• This can precipitate recurrent ischemia, refractory cardiogenic shock, or even cardiac arrest 3

Evidence from Vasospasm Cases

Recent case reports demonstrate the dangers:

• A 2024 case showed refractory cardiogenic shock from coronary spasm requiring ECMO support, which only stabilized with continuous IV nitrates (not beta-blockers) 3
• A 2026 case explicitly warns against non-selective beta-blockers in coronary artery vasospasm management 2
• A 2020 study comparing beta-blockers versus calcium channel blockers after stenting found no difference in preventing vasospasm, but noted beta-blockers may promote DES-induced vasospastic angina 4

Correct Management Approach

First-line therapy for vasospasm-mediated STEMI:

1. Nitrates (sublingual, IV, or intracoronary)

   • Immediate vasodilation
   • Resolves ST-segment elevations 5
   • May require continuous IV administration in severe cases 3

2. Calcium Channel Blockers (long-acting)

   • Primary preventive therapy
   • Diltiazem or amlodipine preferred
   • Should be initiated acutely and continued long-term 5, 2

3. Avoid triggers

   • Smoking cessation
   • Avoid cocaine, amphetamines
   • Manage emotional stress

Critical Diagnostic Pitfall

Coronary vasospasm is frequently missed as a cause of ST-elevation 5. Key diagnostic features:

• ST-elevations that resolve with nitroglycerin 5
• Normal or near-normal coronary angiography
• Positive acetylcholine provocation testing (diagnostic gold standard) 2
• May occur during anesthesia induction or other stress 3

When Beta-Blockers ARE Indicated Post-ACS

The standard ACS guidelines apply only when vasospasm is excluded as the etiology 1:

• Atherosclerotic plaque rupture/thrombosis
• LVEF ≤40% with heart failure
• No evidence of active bronchospasm or cardiogenic shock
• No high-degree AV block

Bottom Line Algorithm

For STEMI with suspected/confirmed vasospasm:

1. ❌ Do NOT give beta-blockers
2. ✅ Give immediate nitrates (sublingual/IV)
3. ✅ Start calcium channel blocker
4. ✅ Perform coronary angiography with provocation testing if diagnosis unclear
5. ✅ Continue nitrates + CCB long-term
6. ✅ Consider ICD if cardiac arrest occurred 3

For typical atherosclerotic STEMI (vasospasm excluded):

1. ✅ Start oral beta-blocker within 24 hours 1
2. Use low dose initially, titrate slowly
3. Monitor for contraindications (shock, heart failure, bradycardia)

The key is recognizing that not all STEMIs are the same—vasospasm requires the opposite pharmacologic approach compared to typical atherosclerotic ACS.